Core theme across FoReCaST (3D cancer models), Gene2Skin (skin therapies), PrinTendon (bioprinted tendon), ATLAS, ELASTISLET, Tendon Therapy Train, and UNICAT (biomaterial catheters).
UNIVERSIDADE DO MINHO
Portuguese university strong in tissue engineering, biomaterials, and open science, with growing capacity in graphene, brain simulation, and sustainability research.
Their core work
Universidade do Minho is a Portuguese research university with deep strengths in biomaterials, tissue engineering, and regenerative medicine — designing scaffolds, bioprinted constructs, and cell-based therapies for skin, tendon, and disease modeling. They are also a significant contributor to European open science infrastructure (OpenAIRE, EOSC) and research data management. More recently, they have expanded into computational neuroscience through the Human Brain Project and into advanced materials via the Graphene Flagship, positioning themselves at the intersection of life sciences and high-performance computing.
What they specialise in
Sustained involvement in OpenAIRE2020, RItrain, and multiple CSA projects focused on open access infrastructure, research information systems, and EOSC development.
Participation in GrapheneCore1 and related projects on graphene-based technologies, 2D materials for semiconductor inks, and self-healing materials.
Contributed to the Human Brain Project (HBP SGA1) on brain simulation, neuroinformatics, neuromorphic computing, and high-performance computing for neural reconstruction.
Recent keyword clusters around sustainability, global changes, green chemistry, polyphenols, and bio-derived volatile fatty acids (VOLATILE project).
Multiple projects on responsible research and innovation (SCILIFE, EQUAL-IST, RISEWISE, EXCHANGE) addressing gender equality, disability inclusion, and forensic genetics ethics.
How they've shifted over time
In the early H2020 period (2014–2018), UMinho concentrated heavily on regenerative medicine, biomaterials, and building European open science infrastructure — keywords like "precision medicine," "scaffold," "open access infrastructure," and "research information system" dominated. From 2018 onward, the portfolio broadened significantly: graphene, computational neuroscience (human brain simulation, neuromorphic computing), sustainability, and numerical modelling became prominent. This signals a deliberate expansion from wet-lab biomedical research toward computational methods and materials science with environmental applications.
UMinho is moving toward computationally intensive, materials-driven research — expect future proposals combining biomaterials with simulation, digital twins, or sustainability-focused advanced materials.
How they like to work
UMinho operates primarily as an active partner (68 of 98 projects), but has meaningful coordination experience with 23 projects led — a strong ratio for a Southern European university. With 1,107 unique consortium partners across 54 countries, they are a genuine network hub rather than a repeat-partner institution. Their high CSA count (21 projects) shows they are frequently trusted for coordination support activities, policy engagement, and infrastructure building — not just technical deliverables.
UMinho has collaborated with over 1,100 unique partners across 54 countries, making them one of the most broadly networked Portuguese universities in H2020. Their geographic spread is genuinely pan-European with global reach, not clustered around Iberian or Southern European partners.
What sets them apart
UMinho's rare combination of biomaterials/tissue engineering expertise with strong open science credentials and involvement in flagship programs (Graphene, Human Brain Project) makes them unusually versatile for a mid-sized Portuguese university. They can contribute to both wet-lab experimental work and large-scale computational or infrastructure projects. For consortium builders, they offer a Widening country partner that punches well above its weight — 98 H2020 projects and EUR 38M in funding signals proven capacity and reliability.
Highlights from their portfolio
- FoReCaSTLargest coordinated project (EUR 2.5M) — established UMinho as a leader in 3D cancer disease models for drug screening, a Widening-funded initiative.
- EXCHANGEEUR 1.35M coordinated project on forensic DNA data exchange across the EU, demonstrating unusual breadth beyond biomedical engineering into science-society-law intersections.
- HBP SGA1Participation in the Human Brain Project flagship — one of Europe's largest research initiatives — connecting UMinho to top-tier neuroscience and HPC communities.